Mayo Clinic Joins a $27.7 Million Federal Push to Build One Gene Editing Platform for Rare Immune Disease
Mayo Clinic has signed on as one of three clinical sites for a federally funded project that aims to do something no gene therapy program has managed yet: build a single, reusable system to treat children with rare inherited immune disorders, rather than …